Usefulness of Paroxetine in Depressed Men With Paroxysmal Atrial Fibrillation

American Journal of Cardiology

Volumn 97, Issue 12, 2006, Pages 1749-1751

  Shirayama, Takeshi ^a   Sakamoto, Takashi ^a   Sakatani, Tomohiko ^a   Mani, Hiroki ^a   Yamamoto, Taku ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; APRINDINE; BEPRIDIL; CIBENZOLINE; DIGOXIN; DISOPYRAMIDE; FLECAINIDE; MEXILETINE; PAROXETINE; PILSICAINIDE; PROPAFENONE; SOTALOL; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; HEART ATRIUM FIBRILLATION; HUMAN; MALE; NAUSEA; NERVOUSNESS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DEPRESSION; DRUG THERAPY, COMBINATION; HUMANS; MIDDLE AGED; PAROXETINE; SEROTONIN UPTAKE INHIBITORS;

EID: 33744549186     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.01.038     Document Type: Article

References (9)

1. Di Girolamo E., Di Iorio C., Sabatini P., Leonzio L., Barbone C., and Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope. a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33 (1999) 1227-1230
2. Coumel P. Autonomic influences in atrial tachyarrhythmias. J Cardiovasc Electrophysiol 7 (1996) 999-1007
3. Yamashita T., Murakawa Y., Sezaki K., Inoue M., Hayami N., Shuzui Y., and Omata M. Circadian variation of paroxysmal atrial fibrillation. Circulation 96 (1997) 1537-1541
4. Spyer K.M. Central nervous control of the cardiovascular system. In: Mathias C.J., and Bannister R. (Eds). Autonomic Failure. 4th ed. (1999), Oxford University Press, Oxford, UK 45-55
5. Takata T.S., Wasmund S.L., Smith M.L., Li J.M., Joglar J.A., Banks K., Kowal R.C., Page R.L., and Hamdan M.H. Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation 106 (2002) 1500-1504
6. Carney R.M., Freedland K.E., Miller G.E., and Jaffe A.S. Depression as a risk factor for cardiac mortality and morbidity. a review of potential mechanisms. J Psychosom Res 53 (2002) 897-902
7. Barsky A.J. Psychiatric and behavioral aspects of cardiovascular disease. In: Zipes D.P., Libby P., Bonow R.O., and Braunwald E. (Eds). Braunwald's Heart Disease. 7th ed. (2005), Elsevier, New York, NY 2129-2144
8. Taylor C.B., Youngblood M.E., Catellier D., Veith R.C., Carney R.M., Burg M.M., Kaufmann P.G., Shuster J., Mellman T., Blumenthal J.A., et al., ENRICHD Investigators. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 62 (2005) 792-798
9. Hemeryck A., and Belpaire F.M. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions. an update. Curr Drug Metab 3 (2002) 13-37